Generic drug maker Alphapharm has lost another bid for documents from Sanofi-Aventis in advance of a hearing on Sanofi’s interlocutory application seeking to block the generic drug maker from listing its injector pen on the Pharmaceutical Benefits Scheme.
Seven employee sues network for wages after exit to Ten
First class action to be filed over combustible cladding
Clive Palmer wants second judge out in Queensland Nickel case
Class action bigwig beats appeal of misconduct ruling
Geoffrey Rush accuser tells court she felt ‘trapped’ on stage
Generic drug cos. win trial against Wyeth over Effexor delay
Wyeth must pay a group of generic drug companies for the harm they suffered after the drug maker won interlocutory injunctions blocking their plans to market an extended release generic version of anti-depressant Effexor, in a ruling likely to have a chilling effect on interlocutory injunction grants in pharmaceutical patent cases.